Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy
Authors:
- 11 July 2022
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 548, 215823
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responsesJournal of Experimental Medicine, 2011
- Liver antigen-presenting cellsJournal of Hepatology, 2011
- Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)PLOS ONE, 2010
- Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor CellsThe American Journal of Pathology, 2010
- Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomesCancer Letters, 2009
- Induction of myeloid‐derived suppressor cells by tumor exosomesInternational Journal of Cancer, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- Ceramide Triggers Budding of Exosome Vesicles into Multivesicular EndosomesScience, 2008
- Targeting the Fas/Fas ligand pathway in cancerExpert Opinion on Therapeutic Targets, 2005